港股午評:恆科指大跌3.64%險守3000點 恆指下挫446點 中聯通逆勢漲約3%
格隆匯11月3日丨受隔夜美股下跌影響,港股上午三大指數大幅下跌,恆指跌2.83%下挫446點,國指跌3.06%,恆生科技指數跌3.64%險守3000點關口。盤面上,連續反彈2日的科技股再度下跌使大市承壓,網易、阿里巴巴均跌超6%,百度、京東、騰訊、美團跌幅均超3.5%;此前連續上漲的生物醫藥股大幅回調,康希諾生物回撤超27%,昨日盤中一度飆漲60%;餐飲股、濠賭股、航運股、蘋果概念股、汽車股、香港地產股等紛紛走低。另一方面,發改委稱大力推進大型風光電基地建設,風電股逆勢走強,聯通與騰訊設立混改新公司,促電信股多數上漲,中國聯通漲約3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.